AUCKLAND, New Zealand, May 1, 2025 /PRNewswire/ -- Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed ...
SCYNEXIS, Inc. has announced the resumption of patient dosing in the Phase 3 MARIO study of ibrexafungerp, an oral antifungal medication, following the lifting of a clinical hold by the FDA. This ...
Ministry of Employment and Labor's Ryu Hyun-cheol, Head of the Occupational Safety and Health Bureau (vice-ministerial level), wrote in a Facebook post on the 8th that a certain study is "an important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results